Liver

Rheumatic Disease eJournal Club

Cardiovascular Disease in Patients
With Rheumatoid Arthritis: Results
From the QUEST-RA Study

Publication: Naranjo A et al. Arthritis Res Ther. 2008;10:R30.

Print this Content

 

Release Date: August 13, 2008
Renewal Date: August 27, 2009
Expiration Date: August 27, 2010

 

 

How to Obtain AMA PRA
Category 1 Credit™

  1. Read the provided journal article and slides.
  2. Listen to the
    audio discussion.
  3. Login to your account.
  4. Complete the registration / evaluation form.
  5. Print your personalized
    CME certificate.

Technical Requirements

 

Estimated Time of Completion: 45 minutes

Description
This archived activity is a recording of the live activity that took place on June 25, 2008. The purpose of this activity is to examine the factors associated with cardiovascular morbidity (CV) and mortality in patients with rheumatoid arthritis (RA) and recognize the importance of monitoring and treatment with disease modifying antirheumatic drugs (DMARDs).

Objectives
On completion of this activity, participants should be able to:

  1. Identify factors associated with increased risk of CV events in patients with RA.
  2. Outline the effects of DMARD exposure on CV morbidity, including myocardial infarction and stroke.
  3. Discuss the importance of analyzing data from RA patients in standard clinical practice.

Target Audience
This activity is directed to physicians, nurse practitioners, physician assistants, and other healthcare professionals interested in RA.

Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity may be submitted for American Osteopathic Association Continuing Medical Education credit in Category 2.

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, Ohio

Faculty

Theodore Pincus, MD
Director, Outcomes Research
Department of Rheumatology
New York University Hospital for Joint Diseases
New York, New York

Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:

Leonard Calabrese, DO  
  Consulting: Abbott Laboratories; Genentech; Roche
 
  Teaching and Speaking: Genentech

The following faculty has indicted he has no relationship with, in the context of his presentation, could be perceived as a potential conflict of interest:

Theodore Pincus, MD

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges an educational grant for support of this activity from:

Roche Laboratories, Inc.

This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education and DIME .

CME Disclaimer